Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
Fortive Corporation (FTV): A Closer Look at Its Industrial Technology Focus and Strategy

Fortive Corporation (FTV): A Closer Look at Its Industrial Technology Focus and Strategy

Key Takeaways

  • FTV is the New York Stock Exchange (NYSE) ticker for Fortive Corporation, a diversified industrial technology company headquartered in Everett, Washington.
  • Fortive provides essential technologies, professional instrumentation, software, and services that help customers improve safety, productivity, and workflow efficiency.
  • The company traces its roots to a 2016 spin-off from DHR (Danaher Corporation) and has since reshaped its portfolio through acquisitions and divestitures.
  • Fortive operates two reportable segments: Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS), anchored by well-known brands such as Fluke and ASP.
  • The company's management approach is built on the Fortive Business System (FBS), a continuous-improvement operating model derived from the Danaher Business System.

Introduction

Fortive Corporation designs, develops, manufactures, and markets professional and engineered products, software, and services used across a wide range of end markets. Its solutions help organizations monitor equipment, ensure worker safety, manage facilities, and deliver critical healthcare workflows. In my view, investors often follow FTV as a way to gain exposure to essential, often recurring-demand technologies sold to manufacturers, utilities, healthcare providers, and other industries worldwide.

Company Overview and History

Fortive was incorporated in 2015 and began trading as an independent public company in July 2016, when it was spun off from DHR (Danaher Corporation). The separation created a focused industrial technology business while Danaher retained its life sciences and diagnostics operations. Fortive subsequently spun off VNT (Vontier Corporation) in 2020, further concentrating its portfolio. The company is headquartered in Everett, Washington, and sells its products in approximately 50 countries.

Fortive's culture is rooted in the Fortive Business System (FBS), a continuous-improvement and lean-management methodology adapted from the Danaher Business System. FBS underpins how the company runs its operations, integrates acquisitions, and drives productivity and margin improvement across its businesses. One thing that stands out here is how this system provides a repeatable framework for execution.

Business Model and Market Position

Fortive generates revenue by selling professional instrumentation, hardware, software subscriptions, and services, many of which carry recurring or consumable-driven demand. This mix gives the company a comparatively resilient financial profile across economic cycles. Its businesses generally hold leading positions in niche, technical markets where switching costs and regulatory or safety requirements are high. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Fortive's two reportable segments are:

  • Intelligent Operating Solutions (IOS): Provides advanced instrumentation, software, and services for maintenance, repair, measurement, condition monitoring, facility and asset lifecycle management, and connected-worker safety. Key brands include Fluke, Accruent, Gordian, Industrial Scientific, Intelex, and ServiceChannel.
  • Advanced Healthcare Solutions (AHS): Supplies critical workflow solutions such as instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and clinical productivity software. Key brands include ASP, Censis, Fluke Biomedical, Landauer, and Provation.

In 2024, Fortive announced plans to separate its Precision Technologies (PT) segment—home to brands such as Tektronix—into an independent public company. That separation was completed on June 28, 2025, creating a new company named Ralliant Corporation, leaving Fortive focused on its IOS and AHS segments.

Why Investors Follow FTV

Investors track FTV for several structural reasons. First, the company's portfolio skews toward essential, mission-critical workflows, which supports recurring revenue and relatively stable demand. Second, its strong brand positions—particularly Fluke in professional test and measurement tools—provide durable competitive advantages and pricing power. Third, the Fortive Business System gives management a repeatable playbook for improving margins and integrating acquisitions, a strategy the company has used to reshape its portfolio over time.

The company's exposure to long-term trends such as industrial digitization, connected-worker safety, asset health monitoring, and healthcare productivity is another factor that attracts investor attention. Because many of Fortive's products are embedded in customers' daily operations, its financial profile tends to emphasize recurring software and service revenue alongside hardware and consumables.

Risks and Important Considerations

As with any industrial technology company, Fortive faces risks that investors should weigh carefully. The company operates in competitive markets and must continually innovate to maintain its market position against larger and smaller rivals. Its performance can be sensitive to macroeconomic conditions, including industrial capital spending, manufacturing activity, and healthcare budgets.

Fortive is also exposed to currency fluctuations and global trade dynamics given its international footprint, and it relies on a network of suppliers and channel partners. Its acquisition-driven strategy carries integration and execution risk, while a meaningful portion of its balance sheet consists of intangible assets such as goodwill, which could be subject to future impairment. Finally, portfolio changes—such as the recent separation of the Precision Technologies segment—can temporarily affect reported results and require investors to adjust how they evaluate the business.

Conclusion

Fortive Corporation is a focused industrial technology company built around essential, workflow-critical products and software, with leading brands such as Fluke and ASP serving manufacturing, utilities, and healthcare customers worldwide. Its disciplined operating model, recurring-revenue characteristics, and history of active portfolio management distinguish it within the broader industrial sector. While the business carries the typical risks of competition, macroeconomic cyclicality, and acquisition execution, Fortive remains a notable example of a company that combines technical product leadership with a systematic approach to continuous improvement. I'm watching this closely as the company continues to refine its focus.

Using Tickeron’s AI Screener in Research

In my own process, I often turn to Tickeron’s AI Screener to help surface and compare ideas like FTV against peers. This platform lets users apply technical indicators, fundamentals, AI signals, and other filters to narrow down opportunities efficiently and align them with individual strategies.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FTV

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


FTV in upward trend: 10-day moving average broke above 50-day moving average on October 21, 2026

The 10-day moving average for FTV crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

FTV moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for FTV moved above the 200-day moving average on November 12, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where FTV advanced for three days, in 148 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.

The Aroon Indicator entered an Uptrend today. In 85 of 201 cases where FTV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 42%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FTV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.

FTV broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 13 (best 1 - 100 worst), indicating outstanding price growth. FTV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 52 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.

The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.258) is normal, around the industry mean (1.448). P/E Ratio (38.228) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (0.983) is also within normal values, averaging (5.470). Dividend Yield (0.004) settles around the average of (0.012) among similar stocks. P/S Ratio (4.077) is also within normal values, averaging (32.028).

The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 7.99B. The market cap for tickers in the group ranges from 12.56K to 120.89B. KYCCF holds the highest valuation in this group at 120.89B. The lowest valued company is FLXT at 12.56K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was 5%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -13%. FCUV experienced the highest price growth at 130%, while ARAI experienced the biggest fall at -51%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was 87%. For the same stocks of the Industry, the average monthly volume growth was 232% and the average quarterly volume growth was 107%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 50
Price Growth Rating: 61
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: 6 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator of industrial units that manufacture testing and measurement equipment

Industry ElectronicEquipmentInstruments

Industry
Electronic Equipment Or Instruments
Address
6920 Seaway Boulevard
Phone
+1 425 446-5000
Employees
10000
Web
https://www.fortive.com
Interact to see
Advertisement
The central price target used here is $400 , roughly 35% above Alphabet's latest verified closing price of $295.77 (November 13, 2026). This target is the arithmetic mean of verified analyst price targets reviewed, not a single analyst's forecast; independent data providers report comparable consensus averages in the high-$390s to low-$400s.
Upcoming catalysts: Integration of advertising into AI Overviews and Gemini conversations, the scaling of Gemini 3 and newer models across Search and Cloud, and the commercial ramp of the $32 billion Wiz cloud-security acquisition could all shape sentiment into 2026. Strategic positioning: Alphabet's vertically integrated artificial intelligence (AI) stack — from custom TPU (Tensor Processing Unit) chips to the Gemini models to Google Cloud — supports a durable, cost-advantaged position in the AI build-out.
The TETH exchange-traded fund (ETF) is the 21Shares Ethereum Staking ETF, a spot Ethereum fund listed on Cboe BZX, and it does not carry conventional analyst price targets. The $14 objective used here is a technical milestone discussed in public market commentary — roughly the zone where Ethereum could begin confirming a recovery — not an analyst consensus.
The central target of $6.70 is the arithmetic mean of seven recent, individually verified analyst price targets, rounded from $6.67. At a latest price near $3.70, reaching $6.70 would require roughly 81% upside — a very large move.
Lead catalyst: Chemomab has secured alignment with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) on a single Phase 3 registration trial for nebokitug in primary sclerosing cholangitis (PSC), a rare liver disease with no approved disease-modifying therapy. Strategic pivot: A planned merger with Scipher Medicine is expected to close by year-end 2026, extending nebokitug into an AI-powered, precision-medicine Phase 2 trial in rheumatoid arthritis (RA).